Item Type | Name |
Academic Article
|
Gel stretch method: a new method to measure constitutive properties of cardiac muscle cells.
|
Academic Article
|
Role of microtubules in the contractile dysfunction of hypertrophied myocardium.
|
Academic Article
|
Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.
|
Academic Article
|
Retinoid signaling required for normal heart development regulates GATA-4 in a pathway distinct from cardiomyocyte differentiation.
|
Academic Article
|
Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors.
|
Academic Article
|
Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading.
|
Academic Article
|
Mechanisms of cardiac hypertrophy in canine volume overload.
|
Academic Article
|
Constitutive properties of adult mammalian cardiac muscle cells.
|
Academic Article
|
Initial retinoid requirement for early avian development coincides with retinoid receptor coexpression in the precardiac fields and induction of normal cardiovascular development.
|
Academic Article
|
Abnormal anteroposterior and dorsoventral patterning of the limb bud in the absence of retinoids.
|
Academic Article
|
Beta3-integrin-mediated focal adhesion complex formation: adult cardiocytes embedded in three-dimensional polymer matrices.
|
Academic Article
|
Abnormalities of somite development in the absence of retinoic acid.
|
Academic Article
|
Microtubule depolymerization normalizes in vivo myocardial contractile function in dogs with pressure-overload left ventricular hypertrophy.
|
Academic Article
|
Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy.
|
Academic Article
|
beta-Adrenergic and endothelin receptor interaction in dilated human cardiomyopathic myocardium.
|
Academic Article
|
Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy.
|
Academic Article
|
New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.
|
Academic Article
|
Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: effects on left ventricular volume and function.
|
Academic Article
|
Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.
|
Academic Article
|
Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
|
Academic Article
|
Structural components of cardiomyocyte remodeling: summation.
|
Academic Article
|
Peter C. Gazes: physician, teacher, scholar.
|
Academic Article
|
Heart failure in aortic stenosis - improving diagnosis and treatment.
|
Academic Article
|
Heart failure with preserved ejection fraction: is this diastolic heart failure?
|
Academic Article
|
Load-dependent left ventricular relaxation in conscious dogs.
|
Academic Article
|
A novel tubular scaffold for cardiovascular tissue engineering.
|
Academic Article
|
Left ventricular function after surgical correction of chronic mitral regurgitation.
|
Academic Article
|
Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.
|
Academic Article
|
Anterior endoderm is sufficient to rescue foregut apoptosis and heart tube morphogenesis in an embryo lacking retinoic acid.
|
Academic Article
|
Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function.
|
Academic Article
|
Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure.
|
Academic Article
|
Treating diastolic heart failure with statins: "phat" chance for pleiotropic benefits.
|
Academic Article
|
Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance.
|
Academic Article
|
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
|
Academic Article
|
Comparison of variability associated with sample preparation in two-dimensional gel electrophoresis of cardiac tissue.
|
Academic Article
|
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
|
Academic Article
|
Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation.
|
Academic Article
|
Integrin activation and focal complex formation in cardiac hypertrophy.
|
Academic Article
|
Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy.
|
Academic Article
|
Normal myocardial function in severe right ventricular volume overload hypertrophy.
|
Academic Article
|
Preliminary report on high thoracic epidural analgesia: relationship between its therapeutic effects and myocardial blood flow as assessed by stress thallium distribution.
|
Academic Article
|
Diastolic heart failure: diagnosis and treatment.
|
Academic Article
|
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
|
Academic Article
|
Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure.
|
Academic Article
|
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
|
Academic Article
|
Mechanical loads and the isovolumic and filling indices of left ventricular relaxation.
|
Academic Article
|
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
|
Academic Article
|
In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.
|
Academic Article
|
Cardiopulmonary exercise variables in diastolic versus systolic heart failure.
|
Academic Article
|
STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX.
|
Academic Article
|
Patterns of structural and functional remodeling of the left ventricle in chronic heart failure.
|
Academic Article
|
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
|
Academic Article
|
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
|
Academic Article
|
Irbesartan in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?
|
Academic Article
|
Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus.
|
Academic Article
|
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
|
Academic Article
|
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
|
Academic Article
|
Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium.
|
Academic Article
|
Distribution of a neutral cardioplegic vehicle during the development of ischemic myocardial contracture.
|
Academic Article
|
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
|
Academic Article
|
Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.
|
Academic Article
|
Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
|
Academic Article
|
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
|
Academic Article
|
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.
|
Academic Article
|
Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy.
|
Academic Article
|
Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium.
|
Academic Article
|
New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.
|
Academic Article
|
Constitutive properties of hypertrophied myocardium: cellular contribution to changes in myocardial stiffness.
|
Academic Article
|
Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment.
|
Academic Article
|
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.
|
Academic Article
|
Abnormal calcium homeostasis: one mechanism in diastolic heart failure.
|
Academic Article
|
Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
|
Academic Article
|
Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.
|
Academic Article
|
Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.
|
Academic Article
|
Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.
|
Academic Article
|
The Heart Failure Society of America in 2020: a vision for the future.
|
Academic Article
|
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
|
Academic Article
|
Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload.
|
Academic Article
|
In vivo measurements of the contributions of protein synthesis and protein degradation in regulating cardiac pressure overload hypertrophy in the mouse.
|
Academic Article
|
Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.
|
Academic Article
|
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
|
Academic Article
|
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
|
Academic Article
|
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency.
|
Academic Article
|
ß3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse.
|
Academic Article
|
Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.
|
Academic Article
|
HFpEF: cardiovascular abnormalities not just comorbidities.
|
Academic Article
|
Membrane-associated matrix proteolysis and heart failure.
|
Academic Article
|
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.
|
Academic Article
|
Changes in extracellular collagen matrix alter myocardial systolic performance.
|
Academic Article
|
Myocardial infarct expansion and matrix metalloproteinase inhibition.
|
Academic Article
|
Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload.
|
Academic Article
|
Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.
|
Academic Article
|
Diastolic heart failure. Diagnosis, prognosis, treatment.
|
Academic Article
|
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
|
Academic Article
|
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.
|
Academic Article
|
Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.
|
Academic Article
|
Mechanical determinants of maximum isotonic lengthening rate in rat left ventricular myocardium.
|
Academic Article
|
Tachycardia-induced cardiomyopathy: effects on blood flow and capillary structure.
|
Academic Article
|
Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
|
Academic Article
|
Evaluation of myocardial function in cardiomyopathic states.
|
Academic Article
|
Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia.
|
Academic Article
|
A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
|
Academic Article
|
Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function.
|
Academic Article
|
Myocardial Na+,K(+)-ATPase in tachycardia induced cardiomyopathy.
|
Academic Article
|
Growth effects of electrically stimulated contraction on adult feline cardiocytes in primary culture.
|
Academic Article
|
Load effects on gene expression during cardiac hypertrophy.
|
Academic Article
|
Direct effects of acute administration of 3, 5, 3' triiodo-L-thyronine on myocyte function.
|
Academic Article
|
Effects of protamine on myocyte contractile function and beta-adrenergic responsiveness.
|
Academic Article
|
Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload.
|
Academic Article
|
The effects of complete versus incomplete mitral valve repair in experimental mitral regurgitation.
|
Academic Article
|
Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function.
|
Academic Article
|
Left ventricular hypertrophy due to volume overload versus pressure overload.
|
Academic Article
|
Contractile properties of isolated porcine ventricular myocytes.
|
Academic Article
|
Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance.
|
Academic Article
|
Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients.
|
Academic Article
|
Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs.
|
Academic Article
|
Effects of pressure- or volume-overload hypertrophy on passive stiffness in isolated adult cardiac muscle cells.
|
Academic Article
|
Cytoskeletal mechanics in pressure-overload cardiac hypertrophy.
|
Academic Article
|
Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience.
|
Academic Article
|
Left ventricular diastolic dysfunction and diastolic heart failure.
|
Academic Article
|
Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.
|
Academic Article
|
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design.
|
Academic Article
|
Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure.
|
Academic Article
|
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
|
Academic Article
|
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
|
Academic Article
|
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.
|
Academic Article
|
Diastolic heart failure: definitions and terminology.
|
Academic Article
|
The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design.
|
Academic Article
|
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure.
|
Academic Article
|
Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients.
|
Academic Article
|
Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function.
|
Academic Article
|
A multidimensional proteomic approach to identify hypertrophy-associated proteins.
|
Academic Article
|
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study.
|
Academic Article
|
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
|
Academic Article
|
New molecular mechanism in diastolic heart failure.
|
Academic Article
|
Chronic aortic and mitral regurgitation. Choosing the optimal time for surgical correction.
|
Academic Article
|
Chronic heart failure: a report from the Dartmouth Diastole Discourses.
|
Academic Article
|
Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.
|
Academic Article
|
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
|
Academic Article
|
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension.
|
Academic Article
|
Myocardial mechanisms causing heart failure early after cardiac transplantation.
|
Academic Article
|
Preload does not affect relaxation rate in normal, hypoxic, or hypertrophic myocardium.
|
Academic Article
|
Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.
|
Academic Article
|
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
|
Academic Article
|
Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload.
|
Academic Article
|
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
|
Academic Article
|
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
|
Academic Article
|
A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart.
|
Academic Article
|
Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
|
Academic Article
|
Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing.
|
Academic Article
|
Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy.
|
Academic Article
|
Calpain inhibition preserves myocardial structure and function following myocardial infarction.
|
Academic Article
|
Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure.
|
Academic Article
|
Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.
|
Academic Article
|
Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
|
Academic Article
|
Chronic ambulatory intracardiac pressures and future heart failure events.
|
Academic Article
|
Fabrication and characterization of bio-engineered cardiac pseudo tissues.
|
Academic Article
|
Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiology.
|
Academic Article
|
Hemodynamic factors associated with acute decompensated heart failure: part 2--use in automated detection.
|
Academic Article
|
The effect of acute alterations in left ventricular afterload and beta-adrenergic tone on indices of early diastolic filling rate.
|
Academic Article
|
Left ventricular diastolic function and exercise capacity in community-dwelling adults =65 years of age without heart failure.
|
Academic Article
|
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
|
Academic Article
|
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension.
|
Academic Article
|
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
|
Academic Article
|
Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry.
|
Academic Article
|
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
|
Academic Article
|
The learning curve for sentinel node biopsy in breast cancer: practical considerations.
|
Academic Article
|
Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
|
Academic Article
|
Effects of autonomic modulation: more than just blood pressure.
|
Academic Article
|
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
|
Academic Article
|
Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing.
|
Academic Article
|
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes.
|
Academic Article
|
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
|
Academic Article
|
Neuromodulation device therapy for treatment of hypertensive heart disease.
|
Academic Article
|
Integrating the myocardial matrix into heart failure recognition and management.
|
Academic Article
|
Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements.
|
Academic Article
|
Left ventricular stress-dimension-shortening relations before and after correction of chronic aortic and mitral regurgitation.
|
Academic Article
|
Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
|
Academic Article
|
Serial changes in left ventricular function after correction of chronic aortic regurgitation. Dependence on early changes in preload and subsequent regression of hypertrophy.
|
Academic Article
|
Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
|
Academic Article
|
Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress.
|
Academic Article
|
Immunologic tests of value in diagnosis. 1. Acute phase reactants and autoantibodies.
|
Academic Article
|
Immunologic tests of value in diagnosis. 2. Complement.
|
Academic Article
|
Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells.
|
Academic Article
|
Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia.
|
Academic Article
|
Left ventricular volume determined echocardiographically by assuming a constant left ventricular epicardial long-axis/short-axis dimension ratio throughout the cardiac cycle.
|
Academic Article
|
The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy.
|
Academic Article
|
Effect of catheter positioning on the variability of measured gradient in aortic stenosis.
|
Academic Article
|
Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes.
|
Academic Article
|
Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus.
|
Academic Article
|
Left ventricular hypertrophy in a canine model of reversible pressure overload.
|
Academic Article
|
Comparative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture.
|
Academic Article
|
Effects of anisosmotic stress on cardiac muscle cell length, diameter, area, and sarcomere length.
|
Concept
|
Microscopy, Electron, Scanning
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Cytokines
|
Concept
|
Body Mass Index
|
Concept
|
Tacrolimus
|
Concept
|
Muscle, Smooth, Vascular
|
Concept
|
Insulin
|
Concept
|
Matrix Metalloproteinase 14
|
Concept
|
Bupivacaine
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Protein Binding
|
Concept
|
Extracellular Matrix
|
Concept
|
Activities of Daily Living
|
Concept
|
Age Factors
|
Concept
|
Neutrophils
|
Concept
|
Russia
|
Concept
|
Triiodothyronine, Reverse
|
Concept
|
Disease Models, Animal
|
Concept
|
Precision Medicine
|
Concept
|
Myocardial Ischemia
|
Concept
|
Ambulatory Care
|
Concept
|
Receptors, Adrenergic, beta-2
|
Concept
|
Interleukin-10
|
Concept
|
Calcium Channel Blockers
|
Concept
|
Necrosis
|
Concept
|
Aortic Valve
|
Concept
|
Temperature
|
Concept
|
Exercise Therapy
|
Concept
|
Echocardiography, Doppler, Color
|
Concept
|
Databases, Factual
|
Concept
|
Glucuronic Acid
|
Concept
|
Rats, Inbred WKY
|
Concept
|
Heart Arrest
|
Concept
|
Patient Selection
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Cardiography, Impedance
|
Concept
|
Aortic Valve Insufficiency
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Microscopy, Electron
|
Concept
|
Blood Urea Nitrogen
|
Concept
|
Terminology as Topic
|
Concept
|
Life Expectancy
|
Concept
|
NF-kappa B
|
Concept
|
Angina Pectoris
|
Concept
|
Blood Pressure
|
Concept
|
Ouabain
|
Concept
|
Cardiac Volume
|
Concept
|
Protein Processing, Post-Translational
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Adrenergic beta-Agonists
|
Concept
|
Amnesia
|
Concept
|
Nitrates
|
Concept
|
Sus scrofa
|
Concept
|
Animals, Newborn
|
Concept
|
Muscle Proteins
|
Concept
|
Diacetyl
|
Concept
|
Sodium Potassium Chloride Symporter Inhibitors
|
Concept
|
Hydrogels
|
Concept
|
Tricuspid Valve Insufficiency
|
Concept
|
Immunity, Cellular
|
Concept
|
Tissue Scaffolds
|
Concept
|
Fibroblast Growth Factor 8
|
Concept
|
Mitochondria
|
Concept
|
Osteopontin
|
Concept
|
Hospice Care
|
Concept
|
Costs and Cost Analysis
|
Concept
|
Echocardiography, Doppler
|
Concept
|
Lymphangiogenesis
|
Concept
|
Circadian Rhythm
|
Concept
|
Patient Dropouts
|
Concept
|
Heart Failure, Systolic
|
Concept
|
Incidence
|
Concept
|
Dobutamine
|
Concept
|
Proportional Hazards Models
|
Concept
|
Mitogen-Activated Protein Kinases
|
Concept
|
Recurrence
|
Concept
|
Drug Discovery
|
Concept
|
Sphingolipids
|
Concept
|
Embryo, Mammalian
|
Concept
|
Morbidity
|
Concept
|
Lactic Acid
|
Concept
|
Quebec
|
Concept
|
Hypothermia, Induced
|
Concept
|
Heart Septal Defects, Atrial
|
Concept
|
Hospices
|
Concept
|
Geography
|
Concept
|
Cell Division
|
Concept
|
Heart Valve Prosthesis Implantation
|
Concept
|
Cardiac Output, Low
|
Concept
|
Collagenases
|
Concept
|
Body Size
|
Concept
|
Fibrinolytic Agents
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Actins
|
Concept
|
Sex Distribution
|
Concept
|
Gene Expression
|
Concept
|
Polymers
|
Concept
|
Matrix Metalloproteinase 1
|
Concept
|
Myosins
|
Concept
|
Oligonucleotide Probes
|
Concept
|
Receptors, Endothelin
|
Concept
|
Warfarin
|
Concept
|
Patient Care Team
|
Concept
|
Diabetes Complications
|
Concept
|
Colloids
|
Concept
|
Cats
|
Concept
|
Manometry
|
Concept
|
Canada
|
Concept
|
Models, Economic
|
Concept
|
Dietary Fats
|
Concept
|
Lactates
|
Concept
|
Isoproterenol
|
Concept
|
Pyrazoles
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Sodium-Calcium Exchanger
|
Concept
|
Myocarditis
|
Concept
|
Body Weight
|
Concept
|
Disease Progression
|
Concept
|
Contractile Proteins
|
Concept
|
Hypoglycemic Agents
|
Concept
|
Drug Approval
|
Concept
|
Radiopharmaceuticals
|
Concept
|
Hedgehog Proteins
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Death, Sudden, Cardiac
|
Concept
|
Medication Therapy Management
|
Concept
|
Endothelium, Vascular
|
Concept
|
Electric Stimulation Therapy
|
Concept
|
Aorta, Thoracic
|
Concept
|
Receptors, Cell Surface
|
Concept
|
Patient Discharge
|
Concept
|
Single-Blind Method
|
Concept
|
Catecholamines
|
Concept
|
Electrophoresis, Gel, Two-Dimensional
|
Concept
|
Cell Adhesion
|
Concept
|
Heart Transplantation
|
Concept
|
Intrinsic Factor
|
Concept
|
Registries
|
Concept
|
Gelatinases
|
Concept
|
Sodium-Potassium-Exchanging ATPase
|
Concept
|
Treatment Outcome
|
Concept
|
Far East
|
Concept
|
Macrophages
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Angioplasty, Balloon, Coronary
|
Concept
|
National Institutes of Health (U.S.)
|
Concept
|
Genes, Dominant
|
Concept
|
Tretinoin
|
Concept
|
GTP-Binding Proteins
|
Concept
|
Clinical Trials, Phase III as Topic
|
Concept
|
Cricetinae
|
Concept
|
Administration, Oral
|
Concept
|
Fibronectins
|
Concept
|
Polyribosomes
|
Concept
|
Receptors, Mitogen
|
Concept
|
Potassium
|
Concept
|
Glycation End Products, Advanced
|
Concept
|
Collagen Type I
|
Concept
|
Research Design
|
Concept
|
Confidence Intervals
|
Concept
|
Dogs
|
Concept
|
Chagas Disease
|
Concept
|
Thoracic Vertebrae
|
Concept
|
Sirolimus
|
Concept
|
Antibodies, Antinuclear
|
Concept
|
Pulmonary Valve Insufficiency
|
Concept
|
Myosin Heavy Chains
|
Concept
|
Animals
|
Concept
|
Chi-Square Distribution
|
Concept
|
GATA6 Transcription Factor
|
Concept
|
Syndrome
|
Concept
|
Feasibility Studies
|
Concept
|
Computer Simulation
|
Concept
|
Myocardial Revascularization
|
Concept
|
Terminal Care
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Oncogene Proteins
|
Concept
|
Postoperative Care
|
Concept
|
Hexuronic Acids
|
Concept
|
Blood Pressure Monitors
|
Concept
|
Chronic Disease
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Electrophysiology
|
Concept
|
Societies, Medical
|
Concept
|
Carbon Radioisotopes
|
Concept
|
Developing Countries
|
Concept
|
Double-Blind Method
|
Concept
|
Trans-Activators
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Protein Biosynthesis
|
Concept
|
Triiodobenzoic Acids
|
Concept
|
Disease-Free Survival
|
Concept
|
Algorithms
|
Concept
|
Biopolymers
|
Concept
|
Health Status
|
Concept
|
Random Allocation
|
Concept
|
Mice, Knockout
|
Concept
|
Geriatric Assessment
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Vasodilator Agents
|
Concept
|
Bundle-Branch Block
|
Concept
|
Hydroxamic Acids
|
Concept
|
Cohort Studies
|
Concept
|
Complement Pathway, Classical
|
Concept
|
Antibodies
|
Concept
|
Sarcolemma
|
Concept
|
Quail
|
Concept
|
Tachycardia
|
Concept
|
Receptors, Angiotensin
|
Concept
|
Natriuretic Peptide, Brain
|
Concept
|
Coronary Artery Disease
|
Concept
|
Myocytes, Cardiac
|
Concept
|
Cell Respiration
|
Concept
|
Electric Impedance
|
Concept
|
Stroke
|
Concept
|
Sample Size
|
Concept
|
Mortality
|
Concept
|
Genes, fos
|
Concept
|
Culture Media
|
Concept
|
Death, Sudden
|
Concept
|
Calcium
|
Concept
|
Adenylyl Cyclases
|
Concept
|
United States Department of Veterans Affairs
|
Concept
|
Intracellular Membranes
|
Concept
|
Acute Disease
|
Concept
|
Propranolol
|
Concept
|
Pulmonary Artery
|
Concept
|
Troponin
|
Concept
|
STAT3 Transcription Factor
|
Concept
|
Chemotaxis
|
Concept
|
Blotting, Western
|
Concept
|
Analgesics, Opioid
|
Concept
|
C-Reactive Protein
|
Concept
|
Angioedema
|
Concept
|
Sarcomeres
|
Concept
|
Protein Precursors
|
Concept
|
Regression Analysis
|
Concept
|
Cardiomyopathies
|
Concept
|
Arteries
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Ferricyanides
|
Concept
|
Heart Failure
|
Concept
|
Myocardial Infarction
|
Concept
|
Spironolactone
|
Concept
|
Diabetes Mellitus
|
Concept
|
Constriction
|
Concept
|
Heart Defects, Congenital
|
Concept
|
Microtomy
|
Concept
|
Retinoids
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Disease Management
|
Concept
|
Hydrochlorothiazide
|
Concept
|
Diabetic Nephropathies
|
Concept
|
Microtubules
|
Concept
|
Aminobutyrates
|
Concept
|
Integrin beta3
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Biopsy
|
Concept
|
Myocardium
|
Concept
|
Coronary Angiography
|
Concept
|
S100 Proteins
|
Concept
|
GATA4 Transcription Factor
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Cranial Sinuses
|
Concept
|
Asia
|
Concept
|
Extracellular Matrix Proteins
|
Concept
|
Clinical Protocols
|
Concept
|
Shc Signaling Adaptor Proteins
|
Concept
|
Infusions, Intravenous
|
Concept
|
Postoperative Complications
|
Concept
|
Vascular Endothelial Growth Factor D
|
Concept
|
Caspase 3
|
Concept
|
Obesity
|
Concept
|
Energy Metabolism
|
Concept
|
Logistic Models
|
Concept
|
Angiotensins
|
Concept
|
Chromatography, Gel
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
Enzyme Induction
|
Concept
|
Procollagen
|
Concept
|
Natriuretic Peptides
|
Concept
|
Galectin 3
|
Concept
|
Mice
|
Concept
|
Contrast Media
|
Concept
|
Electrodes, Implanted
|
Concept
|
Cardiovascular Agents
|
Concept
|
Arrhythmias, Cardiac
|
Concept
|
Synovial Fluid
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Nitroprusside
|
Concept
|
Aortic Valve Stenosis
|
Concept
|
Diastole
|
Concept
|
Models, Biological
|
Concept
|
Neprilysin
|
Concept
|
Epilepsy
|
Concept
|
Rats, Inbred SHR
|
Concept
|
Vitamin A
|
Concept
|
Statistics, Nonparametric
|
Concept
|
Linear Models
|
Concept
|
Computer-Aided Design
|
Concept
|
Neutral Ceramidase
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Sympathetic Nervous System
|
Concept
|
Hypertrophy, Left Ventricular
|
Concept
|
Transcription, Genetic
|
Concept
|
Echocardiography
|
Concept
|
Microscopy, Confocal
|
Concept
|
Pacemaker, Artificial
|
Concept
|
Histone Deacetylases
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
Concept
|
Coronary Artery Bypass
|
Concept
|
Renin
|
Concept
|
Antihypertensive Agents
|
Concept
|
Europe, Eastern
|
Concept
|
Glomerulonephritis
|
Concept
|
Xenopus Proteins
|
Concept
|
Intra-Aortic Balloon Pumping
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Hypertrophy, Right Ventricular
|
Concept
|
Capillaries
|
Concept
|
Tissue Engineering
|
Concept
|
Immediate-Early Proteins
|
Concept
|
Furosemide
|
Concept
|
Receptors, Adrenergic, beta
|
Concept
|
Diabetes Mellitus, Type 2
|
Concept
|
Matrix Metalloproteinase 2
|
Concept
|
Sarcoplasmic Reticulum
|
Concept
|
Treatment Failure
|
Concept
|
Defibrillators, Implantable
|
Concept
|
Complement System Proteins
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
Concept
|
Captopril
|
Concept
|
Bone Morphogenetic Proteins
|
Concept
|
Lysine
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
Concept
|
Retrospective Studies
|
Concept
|
Proto-Oncogene Proteins c-akt
|
Concept
|
Growth Differentiation Factor 15
|
Concept
|
Tissue Inhibitor of Metalloproteinase-2
|
Concept
|
Endoderm
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Cost Savings
|
Concept
|
Models, Statistical
|
Concept
|
Cells, Cultured
|
Concept
|
Dangerous Behavior
|
Concept
|
Mineralocorticoid Receptor Antagonists
|
Concept
|
Biocompatible Materials
|
Concept
|
Cardiac Glycosides
|
Concept
|
Tachycardia, Supraventricular
|
Concept
|
Tyrosine
|
Concept
|
Fontan Procedure
|
Concept
|
Mice, Transgenic
|
Concept
|
Cell Separation
|
Concept
|
Isomerism
|
Concept
|
Mitochondria, Heart
|
Concept
|
Proteins
|
Concept
|
Parasympathetic Nervous System
|
Concept
|
Myofibrils
|
Concept
|
Matrix Metalloproteinase 13
|
Concept
|
Multivariate Analysis
|
Concept
|
Oxygen
|
Concept
|
Early Growth Response Protein 1
|
Concept
|
Decision Support Techniques
|
Concept
|
Mitral Valve Insufficiency
|
Concept
|
Limb Buds
|
Concept
|
Quality of Life
|
Concept
|
Antigens, CD
|
Concept
|
Heart Septum
|
Concept
|
Adenosine
|
Concept
|
Isotope Labeling
|
Concept
|
Heart Rate
|
Concept
|
Monocytes
|
Concept
|
Hospitalization
|
Concept
|
Proteinuria
|
Concept
|
Ventricular Dysfunction, Left
|
Concept
|
Exercise
|
Concept
|
Intestine, Small
|
Concept
|
Severity of Illness Index
|
Concept
|
RNA, Messenger
|
Concept
|
Patient Care Planning
|
Concept
|
Cell Proliferation
|
Concept
|
Collagen Type III
|
Concept
|
Survival Rate
|
Concept
|
Humans
|
Concept
|
Palmitic Acids
|
Concept
|
Heart
|
Concept
|
Doxorubicin
|
Concept
|
Receptors, CXCR3
|
Concept
|
Patient Admission
|
Concept
|
Transgenes
|
Concept
|
Organ Size
|
Concept
|
Cell Movement
|
Concept
|
Laminin
|
Concept
|
Heart Conduction System
|
Concept
|
Homeodomain Proteins
|
Concept
|
Pilot Projects
|
Concept
|
Receptor, Angiotensin, Type 1
|
Concept
|
Sphingosine N-Acyltransferase
|
Concept
|
Methods
|
Concept
|
Focal Adhesion Kinase 2
|
Concept
|
Cardiomyopathy, Hypertrophic
|
Concept
|
Europe
|
Concept
|
Proto-Oncogene Proteins c-sis
|
Concept
|
Drug Monitoring
|
Concept
|
History, 20th Century
|
Concept
|
Retinoid X Receptors
|
Concept
|
Angiotensinogen
|
Concept
|
Ventricular Dysfunction
|
Concept
|
Integrin beta1
|
Concept
|
Egtazic Acid
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Cardiomegaly
|
Concept
|
Radioligand Assay
|
Concept
|
Angioplasty, Balloon
|
Concept
|
Longitudinal Studies
|
Concept
|
TRPP Cation Channels
|
Concept
|
Heart Atria
|
Concept
|
Colforsin
|
Concept
|
Zinc Fingers
|
Concept
|
Heart Failure, Diastolic
|
Concept
|
Calpain
|
Concept
|
Benzenesulfonates
|
Concept
|
Cysteine Proteinase Inhibitors
|
Concept
|
Anesthetics, Local
|
Concept
|
Home Care Services
|
Concept
|
Odds Ratio
|
Concept
|
Massachusetts
|
Concept
|
Heart-Assist Devices
|
Concept
|
Genes, Reporter
|
Concept
|
Confusion
|
Concept
|
Macrophages, Peritoneal
|
Concept
|
Autoantibodies
|
Concept
|
Postoperative Period
|
Concept
|
Inflammation
|
Concept
|
Asia, Southeastern
|
Concept
|
Chemokine CX3CL1
|
Concept
|
Cause of Death
|
Concept
|
American Heart Association
|
Concept
|
Blood Glucose
|
Concept
|
Myocardial Reperfusion Injury
|
Concept
|
Matrix Metalloproteinase 7
|
Concept
|
Aorta
|
Concept
|
Radiographic Image Interpretation, Computer-Assisted
|
Concept
|
Sympathectomy
|
Concept
|
Propensity Score
|
Concept
|
Atrial Fibrillation
|
Concept
|
Los Angeles
|
Concept
|
Health Care Costs
|
Concept
|
Heart Arrest, Induced
|
Concept
|
Chemokine CCL5
|
Concept
|
Tetralogy of Fallot
|
Concept
|
Sinoatrial Node
|
Concept
|
Delirium
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
Concept
|
Fibrinolysin
|
Concept
|
Survival Analysis
|
Concept
|
Systole
|
Concept
|
Arthritis, Rheumatoid
|
Concept
|
Norepinephrine
|
Concept
|
Electrolytes
|
Concept
|
Angiotensin II
|
Concept
|
Analysis of Variance
|
Concept
|
Weight Loss
|
Concept
|
Guanylate Cyclase
|
Concept
|
Body Water
|
Concept
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
|
Concept
|
Models, Animal
|
Concept
|
Protease Inhibitors
|
Concept
|
Histone Deacetylase Inhibitors
|
Concept
|
Gold
|
Concept
|
Rheumatoid Factor
|
Concept
|
Cell Culture Techniques
|
Concept
|
Troponin T
|
Concept
|
Clinical Competence
|
Concept
|
Platelet Aggregation Inhibitors
|
Concept
|
Fibroblast Growth Factor 4
|
Concept
|
Epidemiologic Research Design
|
Concept
|
Cyclosporine
|
Concept
|
Preoperative Care
|
Concept
|
Meta-Analysis as Topic
|
Concept
|
Proto-Oncogene Proteins pp60(c-src)
|
Concept
|
Coturnix
|
Concept
|
Inhibitor of Apoptosis Proteins
|
Concept
|
Water-Electrolyte Balance
|
Concept
|
Cost-Benefit Analysis
|
Concept
|
Cross-Linking Reagents
|
Concept
|
Cytoskeleton
|
Concept
|
Tubulin
|
Concept
|
Coronary Disease
|
Concept
|
Takotsubo Cardiomyopathy
|
Concept
|
Anti-Arrhythmia Agents
|
Concept
|
Fibroblast Growth Factors
|
Concept
|
Influenza Vaccines
|
Concept
|
Blood Chemical Analysis
|
Concept
|
Gelsolin
|
Concept
|
Carotenoids
|
Concept
|
Diuretics
|
Concept
|
Medicare
|
Concept
|
Oligonucleotides, Antisense
|
Concept
|
South Carolina
|
Concept
|
Platelet Membrane Glycoproteins
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
Concept
|
Pressoreceptors
|
Concept
|
Physical Endurance
|
Concept
|
Rats, Inbred F344
|
Concept
|
Models, Structural
|
Concept
|
Alabama
|
Concept
|
Lymph Nodes
|
Concept
|
Dementia
|
Concept
|
Adenoviridae
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Baroreflex
|
Concept
|
Patient Compliance
|
Concept
|
Chagas Cardiomyopathy
|
Concept
|
Hospital Costs
|
Concept
|
Palliative Care
|
Concept
|
Models, Cardiovascular
|
Concept
|
Chordae Tendineae
|
Concept
|
Albuminuria
|
Concept
|
Aortic Aneurysm, Thoracic
|
Concept
|
Insulin-Like Growth Factor Binding Proteins
|
Concept
|
Predictive Value of Tests
|
Concept
|
Reproducibility of Results
|
Concept
|
Health Status Disparities
|
Concept
|
Fumarates
|
Concept
|
Hospitals, University
|
Concept
|
Telemetry
|
Concept
|
Endothelin-1
|
Concept
|
Complement Activation
|
Concept
|
Prospective Studies
|
Concept
|
United Kingdom
|
Concept
|
Complement Pathway, Alternative
|
Concept
|
Wnt Proteins
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Rats
|
Concept
|
Collagen Type IV
|
Concept
|
Collagen
|
Concept
|
Least-Squares Analysis
|
Concept
|
Lactosylceramides
|
Concept
|
Diabetes Mellitus, Type 1
|
Concept
|
Fluorobenzenes
|
Concept
|
Ventricular Dysfunction, Right
|
Concept
|
I-kappa B Proteins
|
Concept
|
Mitral Valve
|
Concept
|
Anticoagulants
|
Concept
|
Digoxin
|
Concept
|
Focal Adhesion Protein-Tyrosine Kinases
|
Concept
|
Image Processing, Computer-Assisted
|
Concept
|
Biphenyl Compounds
|
Concept
|
Radionuclide Ventriculography
|
Concept
|
Blood Sedimentation
|
Concept
|
Carotid Arteries
|
Concept
|
Microscopy, Immunoelectron
|
Concept
|
Infant, Newborn
|
Concept
|
Sequence Homology, Nucleic Acid
|
Concept
|
In Situ Hybridization
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Acetates
|
Concept
|
Evidence-Based Medicine
|
Concept
|
Cardiotonic Agents
|
Concept
|
Prediabetic State
|
Concept
|
Podocytes
|
Concept
|
Integrins
|
Concept
|
Losartan
|
Concept
|
GATA5 Transcription Factor
|
Concept
|
Proteomics
|
Concept
|
Creatinine
|
Concept
|
Digitalis Glycosides
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Fibrosis
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Muscle Weakness
|
Concept
|
Cell Line
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
Concept
|
Nitric Oxide Synthase Type II
|
Concept
|
Proto-Oncogene Proteins c-fos
|
Concept
|
Analgesics
|
Concept
|
Walking
|
Concept
|
Cardiomyopathy, Alcoholic
|
Concept
|
Breast Neoplasms
|
Concept
|
Heart Ventricles
|
Concept
|
Practice Patterns, Physicians'
|
Concept
|
Influenza A virus
|
Concept
|
Lymphatic Metastasis
|
Concept
|
Radiography, Interventional
|
Concept
|
Chimera
|
Concept
|
Body Patterning
|
Concept
|
Rats, Sprague-Dawley
|
Concept
|
Peptidyl-Dipeptidase A
|
Concept
|
Length of Stay
|
Concept
|
Swine
|
Concept
|
Adaptor Proteins, Vesicular Transport
|
Concept
|
United States
|
Concept
|
Protein Isoforms
|
Concept
|
Heart Valve Diseases
|
Concept
|
Probability
|
Concept
|
Bayes Theorem
|
Concept
|
Vaccination
|
Concept
|
Exercise Test
|
Concept
|
Sulfonamides
|
Concept
|
Diabetic Angiopathies
|
Concept
|
Myocardial Contraction
|
Concept
|
Asia, Western
|
Concept
|
Arterioles
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Gene Deletion
|
Concept
|
Telemedicine
|
Concept
|
Risk Assessment
|
Concept
|
Exercise Tolerance
|
Concept
|
Databases, Protein
|
Concept
|
Cardiomyopathy, Dilated
|
Concept
|
Testis
|
Concept
|
Risk
|
Concept
|
MicroRNAs
|
Concept
|
Myristic Acid
|
Concept
|
Fibrillar Collagens
|
Concept
|
Risk Factors
|
Concept
|
Weight Gain
|
Concept
|
Bone Morphogenetic Protein 2
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Receptors, CCR2
|
Concept
|
Patient Readmission
|
Concept
|
Vitamin A Deficiency
|
Concept
|
Proto-Oncogene Proteins
|
Concept
|
Gels
|
Concept
|
Dextrans
|
Concept
|
Metalloendopeptidases
|
Concept
|
Blood Proteins
|
Concept
|
Sweden
|
Concept
|
Cyclic AMP
|
Concept
|
Base Sequence
|
Concept
|
Carotid Sinus
|
Concept
|
Papillary Muscles
|
Concept
|
Follow-Up Studies
|
Concept
|
Disorders of Excessive Somnolence
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Heart Diseases
|
Concept
|
Immunohistochemistry
|
Concept
|
Compliance
|
Concept
|
Comorbidity
|
Concept
|
Insurance Benefits
|
Concept
|
Cold Temperature
|
Concept
|
Injections, Intravenous
|
Concept
|
Neurotransmitter Agents
|
Concept
|
Actin Cytoskeleton
|
Concept
|
Mathematics
|
Concept
|
Molecular Sequence Data
|
Concept
|
Congresses as Topic
|
Concept
|
Cardiac-Gated Imaging Techniques
|
Concept
|
Immunoblotting
|
Concept
|
Electrocardiography
|
Concept
|
Genes, Immediate-Early
|
Concept
|
Cell Count
|
Concept
|
Galectins
|
Concept
|
Somites
|
Concept
|
Age Distribution
|
Concept
|
Critical Care
|
Concept
|
Matrix Metalloproteinases
|
Concept
|
Troponin I
|
Concept
|
Ribosomes
|
Academic Article
|
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
|
Academic Article
|
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
|
Academic Article
|
Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
|
Academic Article
|
Systolic and diastolic mechanics in stress cardiomyopathy.
|
Academic Article
|
Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
|
Academic Article
|
Myocardial fibroblast-matrix interactions and potential therapeutic targets.
|
Academic Article
|
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
|
Academic Article
|
Renal sympathetic denervation for blood pressure control: a review of the current evidence and ongoing studies.
|
Academic Article
|
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
|
Academic Article
|
Developing therapies for heart failure with preserved ejection fraction: current state and future directions.
|
Academic Article
|
Age and SPARC change the extracellular matrix composition of the left ventricle.
|
Academic Article
|
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
|
Academic Article
|
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
|
Academic Article
|
The learning curve for sentinel node biopsy in breast cancer: practical considerations.
|
Academic Article
|
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
|
Academic Article
|
The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern.
|
Academic Article
|
Impaired left atrial function in heart failure with preserved ejection fraction.
|
Academic Article
|
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
|
Academic Article
|
Adverse left ventricular remodeling in community-dwelling older adults predicts incident heart failure and mortality.
|
Academic Article
|
Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
|
Academic Article
|
Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?
|
Academic Article
|
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
|
Academic Article
|
A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.
|
Academic Article
|
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
|
Academic Article
|
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
|
Academic Article
|
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
|
Academic Article
|
Estrogen-Related Receptor a (ERRa) is required for adaptive increases in PGC-1 isoform expression during electrically stimulated contraction of adult cardiomyocytes in sustained hypoxic conditions.
|
Academic Article
|
Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
|
Academic Article
|
Liquid-gel partition chromatography of vitamin A compounds; formation of retinoic acid from retinyl acetate in vivo.
|
Academic Article
|
Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease.
|
Academic Article
|
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
|
Academic Article
|
The learning curve for sentinel node biopsy in breast cancer: practical considerations.
|
Academic Article
|
A novel ultrasound predictor of pulmonary capillary wedge pressure assessed by the combination of left atrial volume and function: A speckle tracking echocardiography study.
|
Academic Article
|
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Response to letters regarding article, "systolic and diastolic mechanics in stress cardiomyopathy".
|
Academic Article
|
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
|
Academic Article
|
The learning curve for sentinel node biopsy in breast cancer: practical considerations.
|
Academic Article
|
Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.
|
Academic Article
|
Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.
|
Academic Article
|
Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
|
Academic Article
|
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
|
Academic Article
|
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
|
Academic Article
|
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
|
Academic Article
|
Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure.
|
Academic Article
|
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.
|
Academic Article
|
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
|
Academic Article
|
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
|
Academic Article
|
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.
|
Academic Article
|
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
|
Academic Article
|
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
|
Academic Article
|
How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
|
Academic Article
|
Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.
|
Academic Article
|
Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan.
|
Academic Article
|
Is Biventricular Fibrosis the Mediator of Late Complications in Tetralogy of Fallot?
|
Academic Article
|
Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
|
Academic Article
|
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial.
|
Academic Article
|
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
|
Academic Article
|
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
|
Academic Article
|
Lactosylceramide contributes to mitochondrial dysfunction in diabetes.
|
Academic Article
|
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
|
Academic Article
|
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
|
Academic Article
|
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
|
Academic Article
|
The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
|
Academic Article
|
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
|
Academic Article
|
Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.
|
Academic Article
|
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
|
Academic Article
|
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.
|
Academic Article
|
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
|
Academic Article
|
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial.
|
Academic Article
|
Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
|
Academic Article
|
Geographic variations in the PARADIGM-HF heart failure trial.
|
Academic Article
|
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
|
Academic Article
|
Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.
|
Academic Article
|
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.
|
Academic Article
|
Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.
|
Academic Article
|
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
|
Academic Article
|
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial).
|
Academic Article
|
Diastolic Heart Failure.
|
Academic Article
|
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
|
Academic Article
|
Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
|
Academic Article
|
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
|
Academic Article
|
Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.
|
Academic Article
|
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
|
Academic Article
|
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
|
Academic Article
|
Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients With Chronic Heart Failure.
|
Academic Article
|
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
|
Academic Article
|
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
|
Academic Article
|
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
|
Academic Article
|
Palliative Care for Advanced Heart Failure in a Department of Veterans Affairs Regional Hospice Program: Patient Selection, a Treatment Protocol, and Clinical Course.
|
Academic Article
|
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
|
Academic Article
|
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
|
Academic Article
|
Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
|
Academic Article
|
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.
|
Academic Article
|
Declining Risk of Sudden Death in Heart Failure.
|
Academic Article
|
Health-Related Quality of Life Outcomes in PARADIGM-HF.
|
Academic Article
|
Activation of Inflammatory and Pro-Thrombotic Pathways in Acute Stress Cardiomyopathy.
|
Academic Article
|
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
|
Academic Article
|
Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
|
Academic Article
|
Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium.
|
Academic Article
|
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
|
Academic Article
|
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
|
Academic Article
|
Cardiac macrophages promote diastolic dysfunction.
|
Academic Article
|
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
|
Academic Article
|
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure.
|
Academic Article
|
The learning curve for sentinel node biopsy in breast cancer: practical considerations.
|
Academic Article
|
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
|
Academic Article
|
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).
|
Academic Article
|
Elevated Wall Tension Leads to Reduced miR-133a in the Thoracic Aorta by Exosome Release.
|
Academic Article
|
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
|
Academic Article
|
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
|
Academic Article
|
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
|
Academic Article
|
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial.
|
Academic Article
|
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
|
Academic Article
|
Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
|
Academic Article
|
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
|
Academic Article
|
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
|
Academic Article
|
Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction.
|
Academic Article
|
Safety and Feasibility of a Nocturnal Heart Rate Elevation-Exploration of a Novel Treatment Concept.
|
Academic Article
|
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
|
Academic Article
|
Heart failure with preserved ejection fraction in Asia.
|
Academic Article
|
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
|
Academic Article
|
Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
|
Academic Article
|
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
|
Academic Article
|
Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al.
|
Academic Article
|
Remote Monitoring of Patients With Heart Failure: A White Paper From the Heart Failure Society of America Scientific Statements Committee.
|
Academic Article
|
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
|
Academic Article
|
Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review.
|
Academic Article
|
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
|
Academic Article
|
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
|
Academic Article
|
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
|
Academic Article
|
Heart Failure With Preserved Ejection Fraction in the Young.
|
Academic Article
|
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.
|
Academic Article
|
Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.
|
Academic Article
|
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
|
Academic Article
|
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
|
Academic Article
|
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
|
Academic Article
|
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
|
Academic Article
|
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
|
Academic Article
|
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
|
Academic Article
|
Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).
|
Academic Article
|
Should We Test for Diastolic Dysfunction? How and How Often?
|
Academic Article
|
Mitochondrial biogenesis induced by the ß2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.
|
Academic Article
|
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
|
Academic Article
|
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure.
|
Academic Article
|
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
|
Academic Article
|
Changes in the crystallographic structures of cardiac myosin filaments detected by polarization-dependent second harmonic generation microscopy.
|
Academic Article
|
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
|
Academic Article
|
Repetitive Acute Hemodynamic Load: Progression From Systolic Decompensation to Cellular/Extracellular Compensation to Diastolic Decompensation.
|
Academic Article
|
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
|
Academic Article
|
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
|
Academic Article
|
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
|
Academic Article
|
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
|
Academic Article
|
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
|
Academic Article
|
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
|
Academic Article
|
Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.
|
Academic Article
|
Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation.
|
Academic Article
|
The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.
|
Academic Article
|
The Vexing Problem of HFpEF Therapeutics: Inching Toward Success.
|
Academic Article
|
Changes in Myocardial Microstructure and Mechanics With Progressive Left Ventricular Pressure Overload.
|
Academic Article
|
Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation.
|
Academic Article
|
Pressure overload generates a cardiac-specific profile of inflammatory mediators.
|
Academic Article
|
Prediction of heart failure hospitalizations based on the direct measurement of intrathoracic impedance.
|
Concept
|
Machine Learning
|
Concept
|
Remote Sensing Technology
|
Concept
|
Cardio-Renal Syndrome
|
Concept
|
Multimorbidity
|
Concept
|
Diabetic Cardiomyopathies
|
Concept
|
Mitral Valve Annuloplasty
|
Concept
|
Cardiac Resynchronization Therapy
|
Concept
|
Cardiac Resynchronization Therapy Devices
|
Concept
|
Implantable Neurostimulators
|
Concept
|
Myofibroblasts
|
Concept
|
Adrenergic beta-2 Receptor Agonists
|
Concept
|
Pandemics
|
Concept
|
Adenosine A1 Receptor Antagonists
|
Concept
|
LIM-Homeodomain Proteins
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Weight Reduction Programs
|
Concept
|
Discoidin Domain Receptors
|
Concept
|
Discoidin Domain Receptor 1
|
Concept
|
Walk Test
|
Concept
|
Patient Reported Outcome Measures
|
Concept
|
Insulins
|
Concept
|
Caspase Inhibitors
|
Concept
|
Matrix Metalloproteinase Inhibitors
|
Concept
|
Patient Acuity
|
Concept
|
Cardiac Catheters
|
Concept
|
Patient Outcome Assessment
|
Concept
|
Connectin
|
Concept
|
Observational Studies as Topic
|
Concept
|
Endothelin Receptor Antagonists
|
Concept
|
Non-Randomized Controlled Trials as Topic
|
Concept
|
Transcatheter Aortic Valve Replacement
|
Concept
|
Cardiotoxicity
|
Concept
|
ErbB Receptors
|
Concept
|
Vascular Remodeling
|
Concept
|
ADAMTS1 Protein
|
Concept
|
Frailty
|
Concept
|
Rosuvastatin Calcium
|
Concept
|
Valsartan
|
Concept
|
Formoterol Fumarate
|
Concept
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
|
Concept
|
Guanylyl Cyclase C Agonists
|
Concept
|
S100 Calcium-Binding Protein A4
|
Concept
|
Interleukin-1 Receptor-Like 1 Protein
|
Concept
|
Retinoic Acid Receptor alpha
|
Concept
|
Homeobox Protein Nkx-2.5
|
Concept
|
Hemodynamic Monitoring
|
Concept
|
Angiotensin Receptor Antagonists
|
Concept
|
Drug Substitution
|
Academic Article
|
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
|
Academic Article
|
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
|
Academic Article
|
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
|
Academic Article
|
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
|
Academic Article
|
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
|
Academic Article
|
Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper.
|
Academic Article
|
Covariate adjusted reanalysis of the I-Preserve trial.
|
Academic Article
|
Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
|
Academic Article
|
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
|
Academic Article
|
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
|
Academic Article
|
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
|
Academic Article
|
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis.
|
Academic Article
|
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
|
Academic Article
|
Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
|
Academic Article
|
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.
|
Academic Article
|
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysis.
|
Academic Article
|
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
|
Academic Article
|
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
|
Academic Article
|
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
|
Academic Article
|
Serum potassium in the PARADIGM-HF trial.
|
Academic Article
|
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF.
|
Academic Article
|
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
|
Academic Article
|
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF.
|
Academic Article
|
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
|
Academic Article
|
Prediction of worsening heart failure events and all-cause mortality using an individualized risk stratification strategy.
|
Academic Article
|
Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
|
Academic Article
|
Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction.
|
Academic Article
|
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
|
Academic Article
|
INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction.
|
Academic Article
|
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.
|
Academic Article
|
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis.
|
Academic Article
|
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
|
Academic Article
|
Racial difference in atrial size and extracellular matrix homeostatic response to hypertension: Is this a potential mechanism of reduced atrial fibrillation in African Americans?
|
Academic Article
|
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial.
|
Academic Article
|
Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
|
Academic Article
|
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone.
|
Academic Article
|
Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
|
Academic Article
|
Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
|
Academic Article
|
From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
|
Academic Article
|
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE.
|
Academic Article
|
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial.
|
Academic Article
|
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial.
|
Academic Article
|
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
|
Academic Article
|
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
|
Academic Article
|
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
|
Academic Article
|
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF.
|
Academic Article
|
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
|
Academic Article
|
Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF.
|
Academic Article
|
Mechanisms that limit regression of myocardial fibrosis following removal of left ventricular pressure overload.
|
Academic Article
|
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.
|
Academic Article
|
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure.
|
Academic Article
|
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
|
Academic Article
|
Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes.
|
Academic Article
|
Diastolic Dysfunction With Preserved Ejec |